Can a single TMAO measurement characterize the gut microbiome?

A circulating trimethylamine N-oxide (TMAO) result is best understood as a context-dependent metabolite measurement, not as a general microbiome test. This applies to a single value in a 64-year-old woman as in other adults.

Clinical and interpretive evidence

• A single TMAO measurement cannot characterize overall gut microbial composition, alpha diversity, or functional capacity. In healthy volunteers assessed one year apart, within-person TMAO variation exceeded between-person variation, so one result is not a stable estimate of an individual’s usual exposure or microbiome-related metabolic state.
• A cross-sectional study associated higher fasting plasma TMAO with alpha diversity and differences in community composition. However, an association at the group level does not establish that a value can identify an individual’s microbiome profile, reliably classify diversity, or quantify broad microbial functions.
• Controlled dietary evidence found that fecal microbiome composition did not reliably predict diet-induced systemic TMAO.

Mechanistic explanation

• Microbial contribution: Gut microbes can convert dietary precursors into trimethylamine (TMA).
• Host processing: TMA then enters portal blood and is oxidized primarily by hepatic flavin-containing monooxygenase 3 (FMO3) to TMAO. Variation in FMO3 activity can therefore alter TMAO independently of the overall microbial community.
• Renal handling: TMAO is cleared predominantly through the kidneys; reduced renal clearance can raise blood TMAO without increased microbial production or dietary precursor intake.
• Detection of microbial genes for TMA production indicates metabolic potential, not actual pathway expression or metabolic flux.

Bottom line

• A single TMAO result may reflect one diet–microbe–host metabolic pathway, but it cannot serve as a validated stand-alone descriptor of gut microbiome composition, diversity, or overall function.